{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:35:25Z","timestamp":1761510925440},"reference-count":22,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.vaccine.2009.02.012","type":"journal-article","created":{"date-parts":[[2009,2,14]],"date-time":"2009-02-14T15:23:56Z","timestamp":1234625036000},"page":"2403-2407","source":"Crossref","is-referenced-by-count":11,"title":["Report of the Fifth AREB Meeting"],"prefix":"10.1016","volume":"27","author":[{"given":"B.","family":"Dodet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.02.012_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2005.10.007","article-title":"Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey","volume":"11","author":"Sudarshan","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.012_bib2","unstructured":"WHO position paper on rabies. WER 2008; 82(49\u201350):425\u201336."},{"issue":"24","key":"10.1016\/j.vaccine.2009.02.012_bib3","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1056\/NEJMoa050382","article-title":"Survival after treatment of rabies with induction of coma","volume":"352","author":"Willoughby","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2009.02.012_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/13550280600902295","article-title":"Failure of therapeutic coma and ketamine for therapy of human rabies","volume":"12","author":"Hemachudha","year":"2006","journal-title":"J Neurovirol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.02.012_bib5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.trstmh.2008.04.008","article-title":"Viewpoint: management of human rabies","volume":"102","author":"Wilde","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.012_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/13550280701883857","article-title":"Furious and paralytic rabies of canine origin: neuroimaging with virological and cytokine studies","volume":"14","author":"Laothamatas","year":"2008","journal-title":"J Neurovirol"},{"key":"10.1016\/j.vaccine.2009.02.012_bib7","unstructured":"WHO. WHO expert committee on rabies\u2014eight report; WHO technical report series (TRS) 824, 1992."},{"key":"10.1016\/j.vaccine.2009.02.012_bib8","unstructured":"WHO. WHO expert consultation on rabies\u2014WHO technical report series (TRS) 931. First Report. 2004."},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.012_bib9","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1371\/journal.pntd.0000224","article-title":"A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods","volume":"2","author":"Warrell","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.02.012_bib10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1086\/517241","article-title":"Postexposure rabies vaccination in patients infected with human immunodeficiency virus","volume":"28","author":"Jaijaroensup","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.012_bib11","unstructured":"Children and rabies\u2014World Rabies Day. http:\/\/www.who.int\/phe\/news\/children_and_rabies_07.pdf. 2007."},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.012_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/tropej\/fmm100","article-title":"Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam","volume":"55","author":"Lang","year":"2009","journal-title":"J Trop Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.012_bib13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.trstmh.2007.11.010","article-title":"Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children","volume":"102","author":"Vien","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.02.012_bib14","unstructured":"Pengsaa K, Limkittikul K, Sabchareon A, Ariyasriwatana C, Chanthavanich P, Attanath P, Malerczyk C, et al. A three-year clinical study on immunogenicity, safety and booster response of purified chick embryo cell rabies vaccine (PCECV) administered intramuscularly or intradermally to 12- to 18-month-old Thai children concomitantly with Japanese encephalitis vaccine. Pediatr Infect Dis J; in press."},{"issue":"5","key":"10.1016\/j.vaccine.2009.02.012_bib15","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/515267","article-title":"Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-Year follow-up and proposal for a new booster policy","volume":"177","author":"Strady","year":"1998","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2009.02.012_bib16","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.vaccine.2006.02.027","article-title":"Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity","volume":"24","author":"Suwansrinon","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.012_bib17","unstructured":"WHO. WHO Recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. WHO\/EMC\/ZOO.96.6. 1997."},{"key":"10.1016\/j.vaccine.2009.02.012_bib18","unstructured":"WHO. Intradermal application of rabies vaccines. Report of a WHO consultation. Bangkok, Thailand, June 5\u20136, 2000. WHO\/CDS\/CRS\/APH\/2000.5. 2000."},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.012_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijid.2003.07.001","article-title":"Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen","volume":"8","author":"Madhusudana","year":"2004","journal-title":"Int J Infect Dis"},{"issue":"February 25 (14)","key":"10.1016\/j.vaccine.2009.02.012_bib20","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2004.09.027","article-title":"Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals","volume":"23","author":"Quiambao","year":"2005","journal-title":"Vaccine"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2009.02.012_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tmaid.2007.07.004","article-title":"Preventing rabies with the Verorab vaccine: 1985\u20132005 twenty years of clinical experience","volume":"5","author":"Toovey","year":"2007","journal-title":"Travel Med Infect Dis"},{"issue":"November 25 (50)","key":"10.1016\/j.vaccine.2009.02.012_bib22","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1016\/j.vaccine.2008.09.003","article-title":"Rabies awareness in eight Asian countries","volume":"26","author":"Dodet","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09002382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09002382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T20:55:52Z","timestamp":1545425752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09002382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":22,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0264410X09002382"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}